ArticleFrontiers in public health2026
Awareness, risk perception, and attitudes toward prostate cancer detection and MRI among Armenian men.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prostate cancer is a common malignancy and major cause of cancer mortality among men worldwide. Early detection improves outcomes, but participation depends on awareness, perceived risk, and attitudes toward testing and diagnostic pathways. In Armenia, many cases are diagnosed at advanced stages, partly due to limited screening practices and low public awareness. This study assessed Armenian men's knowledge of prostate cancer, perception of personal risk, and attitudes toward prostate MRI within early-detection pathways, including perceived barriers to undergoing MRI. Methods: A cross-sectional study was conducted from December 2024 to March 2025 at the Proton Diagnostic and Educational Center in Yerevan, Armenia. The study included 196 men aged ≥45 years undergoing MRI examinations unrelated to prostate conditions. Participants completed a structured 38-item questionnaire adapted from validated international surveys assessing awareness, perceived risk, screening attitudes, and barriers to MRI screening. Four perception scores were derived from Likert-scale responses. Associations between sociodemographic factors and perception scores were examined using multivariable linear regression analysis. Results: The mean perceived risk score was 2.95 (SD = 0.73) and the mean awareness score was 3.21 (SD = 0.72). Men aged 56-65 years had a 0.30-point higher perceived risk than those aged 45-55 years (mean difference. = 0.30; 95% CI: 0.05-0.55). Awareness was 0.32 points lower among men with secondary education or less (mean difference = -0.32; 95% CI: -0.57 to -0.07). The mean screening confidence score was 3.45 (SD = 0.81). Perceived barriers to MRI screening were higher among men with secondary education or less (mean difference = 0.39; 95% CI: 0.18-0.60) and those with vocational or technical education (adjusted mean difference = 0.40; 95% CI: 0.19-0.61) than among those with higher education. Conclusion: Awareness of prostate cancer and early detection among Armenian men moderate and varied by education level. Lower educational attainment was consistently associated with lower awareness and greater perceived barriers to MRI-based diagnostic evaluation. Targeted health education and more equitable access to diagnostic services may support earlier detection and help reduce the burden of prostate cancer in Armenia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.